Your browser doesn't support javascript.
loading
Postthrombotic syndrome following upper extremity deep vein thrombosis in children.
Avila, Maria L; Duan, Lucy; Cipolla, Amanda; Kim, Ashley; Kahr, Walter H A; Williams, Suzan; Brandão, Leonardo R.
Afiliação
  • Avila ML; Division of Hematology/Oncology, Department of Pediatrics, and.
  • Duan L; Division of Hematology/Oncology, Department of Pediatrics, and.
  • Cipolla A; Division of Hematology/Oncology, Department of Pediatrics, and.
  • Kim A; Division of Hematology/Oncology, Department of Pediatrics, and.
  • Kahr WH; Division of Hematology/Oncology, Department of Pediatrics, and Department of Biochemistry, University of Toronto, Program in Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.
  • Williams S; Division of Hematology/Oncology, Department of Pediatrics, and.
  • Brandão LR; Division of Hematology/Oncology, Department of Pediatrics, and.
Blood ; 124(7): 1166-73, 2014 Aug 14.
Article em En | MEDLINE | ID: mdl-24957144
ABSTRACT
Despite its relatively estimated high occurrence, the characterization of pediatric upper extremity deep vein thrombosis (UE-DVT) and of UE postthrombotic syndrome (PTS) is still lacking. We investigated the occurrence, characteristics, and predictors of UE-PTS in a cohort of children with objectively confirmed UE-DVT. Patients were analyzed in 3 groups according to DVT pathogenesis and neonatal status primary (G1), secondary neonates (G2neonates), and non-neonates (G2non-neonates). A total of 158 children (23 G1, 25 G2neonates, and 110 G2non-neonates) were included. The most common triggering factors were effort-related (87%) in G1 and central lines in G2neonates (100%) and in G2non-neonates (92%). PTS scores ≥1, as per the Modified Villalta Scale, were identified in 87% of primary patients, 16% of G2neonates, and 49% of G2non-neonates. Survival analysis showed that the time to PTS score ≥1 significantly differed among group (log-rank test P < .0001). A multivariable logistic regression showed that DVT pathogenesis and imaging-determined degree of thrombus resolution at the end of therapy were independent predictors of a PTS score ≥2. In conclusion, pediatric UE-PTS frequency and severity depend on UE-DVT pathogenesis (primary/secondary) and, within the secondary group, on patient's age. Line-related UE-PTS has a more benign course, particularly in neonates.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Síndrome Pós-Trombótica / Trombose Venosa Profunda de Membros Superiores / Trombólise Mecânica / Anticoagulantes Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Síndrome Pós-Trombótica / Trombose Venosa Profunda de Membros Superiores / Trombólise Mecânica / Anticoagulantes Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2014 Tipo de documento: Article